These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2447438)

  • 1. Effects of alpha 1-inhibition on lipid metabolism in the rat.
    Woodside WF; Swindell AC
    J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S27-34. PubMed ID: 2447438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.
    Jansen H; Baggen RG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S16-20. PubMed ID: 2447435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic alpha 1-adrenergic blockade, serum triacylglycerols, and tissue lipoprotein lipase activity in rats fed diets high in starch or sucrose.
    Deshaies Y; Martineau MJ; LaLonde J
    Nutrition; 1991; 7(2):109-15; discussion 115-6. PubMed ID: 1686980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A; Daae LN; Kierulf P; Brusletto B; Holme I; Syvertsen JO
    J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS; Hirokawa WT
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic changes during antihypertensive therapies.
    Krone W; Nägele H
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model.
    Foxall TL; Shwaery GT; Stucchi AF; Nicolosi RJ; Wong SS
    Am J Pathol; 1992 Jun; 140(6):1357-63. PubMed ID: 1351367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade.
    Fliser D; Nowack R; Allendorf-Ostwald N; Kohl B; Hübinger A; Ritz E
    Am J Hypertens; 1993 Apr; 6(4):320-4. PubMed ID: 8099492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of doxazosin on lipid transport in rats and hamsters.
    Ontko JA; Woodside WF
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S31-6; discussions 36-7. PubMed ID: 2471013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term exercise and high-cholesterol diet on lipid-lipoprotein metabolism in rats.
    Terao T; Fujise T; Nakano S
    Tokai J Exp Clin Med; 1987 Nov; 12(4):243-51. PubMed ID: 3503394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-protective role of terazosin is possibly mediated through alteration in thyroid function.
    Jatwa R; Kar A
    Eur J Pharmacol; 2006 Dec; 551(1-3):87-91. PubMed ID: 17027746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terazosin: a new antihypertensive agent with favorable effects on lipids.
    Luther RR
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meal frequency; does it determine postprandial lipaemia?
    Murphy MC; Chapman C; Lovegrove JA; Isherwood SG; Morgan LM; Wright JW; Williams CM
    Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies with doxazosin on the saturable binding of 125I-LDL by liver in normocholesterolemic mice.
    Nanjee MN; Miller NE
    J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S35-41. PubMed ID: 2447439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum lipoprotein lipids and their fatty acid compositions and lipid peroxidation in growing rats fed soybean protein versus casein with or without cholesterol.
    Madani S; Frenoux JM; Prost J; Belleville J
    Nutrition; 2004 Jun; 20(6):554-63. PubMed ID: 15165619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and lipoprotein subfractions in adult guinea pigs.
    Torres-Gonzalez M; Leite JO; Volek JS; Contois JH; Fernandez ML
    J Nutr Biochem; 2008 Dec; 19(12):856-63. PubMed ID: 18495466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin lowers plasma triglyceride concentration in rats: a preliminary report.
    Reaven GM; Dall'Aglio E
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S248-50. PubMed ID: 6177967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.